Table:
begin	end	state
1	36	cytoplasmic
37	54	transmembrane
55	73	non-cytoplasmic
74	97	transmembrane
98	106	cytoplasmic
107	125	transmembrane
126	130	non-cytoplasmic
131	149	transmembrane
150	173	cytoplasmic
174	195	transmembrane
196	200	non-cytoplasmic
201	221	transmembrane
222	271	cytoplasmic
272	295	transmembrane
296	308	non-cytoplasmic
309	333	transmembrane
334	344	cytoplasmic
345	363	transmembrane
364	368	non-cytoplasmic
369	390	transmembrane
391	401	cytoplasmic
402	425	transmembrane
426	430	non-cytoplasmic
431	452	transmembrane
453	480	cytoplasmic

Input:
>PfGW456L13_5043
LTTIASKLAPAKHRYYPHKNNQWEYIYMQSTQKPTHVRYLILLMLFLVTTINYADRATIA
IAGSSLQKDLGIDAVTLGYIFSAFGWAYVAGQIPGGWLLDRFGSKKIYALSIFTWSLFTV
LQGFVGEFGMSTAVVALFMLRFLVGLAEAPSFPGNARIVAAWFPTAERGTASAIFNSAQY
FATVLFAPLMGWIVYSFGWEHVFIVMGILGIIFSLVWLKVIYSPREHPRINDAEFKHISE
NGGMVDMDQKGKKSDGPKWDYIRQLLTNRMMLGVYLGQYCINGITYFFLTWFPVYLVQER
GMTILKAGFIASLPAICGFIGGVLGGVISDYLLRKGHSLTFARKAPIIAGLLVSSSIVAC
NYVDVEWMVVGFMALAFFGKGVGALGWAVVSDTSPKQIAGLSGGLFNTFGNIASITTPIV
IGYIISSTGSFKWALVFVGCNALVAVFSYLVIVGPIKRVVLKEPPANGTEAPGKLSQAHS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server